Cargando…
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model
BACKGROUND: The peptide neurotransmitter N-acetylaspartylglutamate (NAAG) is widely expressed throughout the vertebrate nervous system, including the pain processing neuraxis. Inhibitors of NAAG peptidases are analgesic in animal models of pain. However, the brain regions involved in NAAG's ana...
Autores principales: | Adedoyin, Mary O, Vicini, Stefano, Neale, Joseph H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152775/ https://www.ncbi.nlm.nih.gov/pubmed/20860833 http://dx.doi.org/10.1186/1744-8069-6-60 |
Ejemplares similares
-
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain
por: Yamamoto, Tatsuo, et al.
Publicado: (2008) -
N-Acetylaspartylglutamate (NAAG) Pretreatment Reduces Hypoxic-Ischemic Brain Damage and Oxidative Stress in Neonatal Rats
por: Bratek, Ewelina, et al.
Publicado: (2020) -
The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia
por: Li, Kexin, et al.
Publicado: (2022) -
Dendritic Localization and Exocytosis of NAAG in the Rat Hippocampus
por: Nordengen, K, et al.
Publicado: (2020) -
NAA and NAAG variation in neuronal activation during visual stimulation
por: Castellano, G., et al.
Publicado: (2012)